Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 14INDUSTRY 4UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Locally Advanced Malignant Neoplasm 1Carcinoma, Non-Small-Cell Lung 1

Interventions

icotinib 2Erlotinib Hydrochloride 2pembrolizumab 1camrelizumab 1aumolertinib 1apatinib 1Sunitinib 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Pemetrexed 1Gemcitabine 1Gefitinib 1Drug Therapy 1Cisplatin 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Carcinoma, Non-Small-Cell Lung × Chemoradiotherapy × Clear all
NCT01494558 2011-12-19

Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer

ChineseAMS

Phase 2/3 Completed
200 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡